Approximately 1 in 4 patients being treated in the community have received DNA matched treatment from comprehensive genomic profiling results, indicating that precision medicine is now increasingly utilized in settings other than specialist hospital environments.
Browsing: Taxonomy > Personalized medicine
This November, the European Cancer Patient Coalition (ECPC) is very excited to be leading the first Personalized Medicine Awareness Month.
In a medical breakthrough, a new approach to immunotherapy has led to complete regression of breast cancer in a patient unresponsive to all other treatments.
Researchers have reported that children with incurable brain tumors could benefit from a potentially life-extending treatment, if genetic testing is utilized to personalize their therapy. This personalized treatment has previously only been used in adults.
A novel imaging technology to grade tumor biopsies has been developed by a team of scientists, eradicating human subjectivity and ensuring patients get the correct treatment.
Cancer drugs tested on replicas of tumors could provide information on how individual patients will respond to treatment.
The American Society of Clinical Oncology (ASCO) has named adoptive cell immunotherapy as their clinical cancer Advance of the Year.
Discover the importance of DNA methylation changes in the identification of potential biomarkers relevant for clinical follow-up and personalized medicine of chronic lymphocytic leukemia.
How can ASCO’s CancerLinQ help us manage the vast amount of data required to provide high-quality cancer care?
In a first of its kind study, blood sample analysis detects genomic alterations that can predict which cancer patients should receive checkpoint inhibitor immunotherapy.